日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Biosynthetic formation of the 6/7/5-odyverdiene diterpenes via a 6/10-trans-eunicellanyl intermediate

6/7/5-二萜烯类化合物通过 6/10-反式-尤尼塞拉尼中间体生物合成形成

期刊:ACS Catalysis
影响因子:13.1
doi:10.1021/acscatal.6c00111
Ning, Wenbo; Kong, Wang-Yeuk; Li, Zining; Wei, Xiuting; Nafie, Jordan; Xu, Baofu; Cavassa, Fabrizio G; Huang, Pin-Shuo; Tantillo, Dean J; Rudolf, Jeffrey D
发表日期：2026
文献求助 收藏

Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients

分析慢性丙型肝炎患者接受无干扰素直接抗病毒治疗后肝细胞癌复发的风险因素并建立分层系统

期刊:
影响因子:
doi:10.1097/JCMA.0000000000001051
Luan, Chih-Hsuan; Su, Pin-Shuo; Chu, Chi-Jen; Lin, Chung-Chi; Su, Chien-Wei; Luo, Jiing-Chyuan; Lee, I-Cheng; Chi, Chen-Ta; Lee, Shou-Dong; Wang, Yuan-Jen; Lee, Fa-Yauh; Huang, Yi-Hsiang; Hou, Ming-Chih
肿瘤
肿瘤免疫
微生物学
细胞生物学
肝炎
发表日期：2024
文献求助 收藏

Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response

接受全口服直接抗病毒药物治疗并获得持续病毒学应答的慢性丙型肝炎患者，其发生肝细胞癌的残余风险仍然存在。

期刊:
影响因子:
doi:10.1097/JCMA.0000000000000965
Luan, Chih-Hsuan; Su, Pin-Shuo; Chu, Chi-Jen; Lin, Chung-Chi; Su, Chien-Wei; Lee, Shou-Dong; Wang, Yuan-Jen; Lee, Fa-Yauh; Huang, Yi-Hsiang; Hou, Ming-Chih
肿瘤
肿瘤免疫
微生物学
细胞生物学
肝炎
发表日期：2023
文献求助 收藏

Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis

索非布韦为基础的抗病毒疗法对台湾慢性丙型肝炎失代偿期肝硬化患者具有较高的疗效、安全性和良好的耐受性。

期刊:
影响因子:
doi:10.1097/JCMA.0000000000000653
Su, Pin-Shuo; Wu, Sih-Hsien; Chu, Chi-Jen; Su, Chien-Wei; Lin, Chung-Chi; Lee, Shou-Dong; Wang, Yuan-Jen; Lee, Fa-Yauh; Huang, Yi-Hsiang; Hou, Ming-Chih
微生物学
肝炎
肝硬化
发表日期：2022
文献求助 收藏

Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus-coinfected patients treated by all-oral direct-acting antivirals

全口服直接抗病毒药物治疗丙型肝炎病毒-人类免疫缺陷病毒合并感染患者，耐受性良好，治疗反应高效。

期刊:
影响因子:
doi:10.1097/JCMA.0000000000000528
Su, Pin-Shuo; Su, Chien-Wei; Wu, Sih-Hsien; Wei, Tien-Hsin; Chu, Chi-Jen; Lin, Chung-Chi; Lee, Shou-Dong; Wang, Yuan-Jen; Lee, Fa-Yauh; Huang, Yi-Hsiang; Hou, Ming-Chih
HIV
炎症/感染
微生物学
肝炎
免疫/内分泌
发表日期：2021
文献求助 收藏